![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
![]() |
Recruitment status | Open public recruiting |
Unique ID issued by UMIN | UMIN000004318 |
Receipt No. | R000005173 |
Scientific Title | The relationship between visceral fat accumulation and humoral factors in Japanese subjects. |
Date of disclosure of the study information | 2011/12/01 |
Last modified on | 2011/12/01 |
Basic information | ||
Public title | The relationship between visceral fat accumulation and humoral factors in Japanese subjects. | |
Acronym | Victor-J | |
Scientific Title | The relationship between visceral fat accumulation and humoral factors in Japanese subjects. | |
Scientific Title:Acronym | Victor-J | |
Region |
|
Condition | ||||
Condition | The subjects who have medical health checkup and patients who have or suspected to have cardiovascular disease. | |||
Classification by specialty |
|
|||
Classification by malignancy | Others | |||
Genomic information | NO |
Objectives | |
Narrative objectives1 | We investigate the relationship between visceral fat accumulation and various humoral factors such as adipocytekines, natriuretic petides and oxidative stress markers. |
Basic objectives2 | Others |
Basic objectives -Others | observation study |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | visceral fat, humoral factors such as adipocytekines, natriuretic petides and oxidative stress markers. |
Key secondary outcomes |
In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
Base | |
Study type | Observational |
Study design | |
Basic design | |
Randomization | |
Randomization unit | |
Blinding | |
Control | |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |
No. of arms | |
Purpose of intervention | |
Type of intervention | |
Interventions/Control_1 | |
Interventions/Control_2 | |
Interventions/Control_3 | |
Interventions/Control_4 | |
Interventions/Control_5 | |
Interventions/Control_6 | |
Interventions/Control_7 | |
Interventions/Control_8 | |
Interventions/Control_9 | |
Interventions/Control_10 |
In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | The subjects who have medical health checkup and patients who have or are suspected to have cardiovascular disease. | |||
Key exclusion criteria | not suitable for this study (doctor desises) | |||
Target sample size | 100 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Osaka university | ||||||
Division name | Metabolic Medicine | ||||||
Zip code | |||||||
Address | 2-2-B5, Yamada-oka, Suita, Osaka, 565-0871, Japan | ||||||
TEL | |||||||
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Osaka university | ||||||
Division name | Metabolic Medicine | ||||||
Zip code | |||||||
Address | 2-2-B5, Yamada-oka, Suita, Osaka, 565-0871, Japan | ||||||
TEL | |||||||
Homepage URL | |||||||
Sponsor | |
Institute | Osaka university |
Institute | |
Department |
Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
Funding Source | |
Organization | Osaka university |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Open public recruiting | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date | |||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information | We investigate the relationship between visceral fat accumulation and various humoral parameters such as adipocytekines, natriuretic peptides and oxidative stress markers. |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005173 |